DIABNEXT was founded with the vision of developing highly innovative solutions that help people with diabetes better manage their chronic condition and improve their care and quality of life. Through collaboration with many leaders and clinicians in diabetes healthcare, the DIABNEXT platform offers patients a unique solution that enables remote monitoring, coordination, therapeutic education and analytics of data related to blood glucose, insulin, diet and physical activity automatically through connected health devices. DIABNEXT was acquired by Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, in March 2022. The DIABNEXT platform is now marketed under the name Glooko XT.
| Website | http://diabnext.com |
| Employees | 4 (2 on RocketReach) |
| Address | 10, Rue Treilhard, Paris, Île-de-France 75008, FR |
| Technologies |
JavaScript
,
HTML
,
PHP
+32 more
(view full list)
|
| Industry | Wellness and Fitness Services, Diabetes, Artificial intelligence, Internet of Things, Health, Ehealth |
| Keywords | Diabetes Management, Diabetes Care Solutions, Diabetes Technology, Diabetes Self Management, Improving Diabetes Care, Chronic Disease Management, Personalized Diabetes Care, Patient Engagement Platform, Type 1 Diabetes Management, Type 2 Diabetes Management, Glucose Monitoring System, Diabetes Prevention Programs |
Looking for a particular DIABNEXT employee's phone or email?
DIABNEXT Questions
Singing Lin is the Regional Chief Financial Officer, Asia of DIABNEXT.
2 people are employed at DIABNEXT.
DIABNEXT is based in Paris, Île-de-France.
Top DIABNEXT Employees
Related Companies
